Company intelligence / Profile preview

Yunnan Shengke Pharmaceutical

Kunming, Yunnan, Chinahys.cn ↗

Ownership: Private
Development stage: Commercial

Overview

Yunnan Shengke Pharmaceutical is a private pharmaceutical company based in Kunming, Yunnan Province, China. It focuses on the development and commercialization of herbal medicines. Its lead product, SanQi LongXueJie Capsule, is approved in China for cardiovascular diseases. The company has also published preclinical results showing efficacy of a compound ("4b") as an inhibitor of colitis in animal models. There is no evidence of large-scale clinical trials or multiple late-stage assets.

Therapeutic areas: GastroenterologyCardiovascular
Modalities: Herbal medicineSmall molecule
Industry: Biotech

Drug pipeline

2 assets

Dan'e Fukang Jiangao

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Yunnan Shengke Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunnan Shengke Pharmaceutical.

Explore the full profile